Liraglutide and Glycaemic Outcomes in the LEADER Trial

Zinman, B; Nauck, MA; Bosch-Traberg, H; Frimer-Larsen, H; Orsted, DD; Buse, JB

Zinman, B (reprint author), Univ Toronto, Lunenfeld Tanenbaum Res Inst, Mt Sinai Hosp, Toronto, ON, Canada.

DIABETES THERAPY, 2018; 9 (6): 2383

Abstract

IntroductionThe LEADER trial was a cardiovascular (CV) outcomes trial in patients with type 2 diabetes at high CV risk that compared liraglutide (n=46......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索